Stocks:
5,167
ETFs:
2,288
Exchanges:
11
Market Cap:
$62.23T
24h Vol:
$11.14B
Dominance:
MSFT:4.87%
Stocklytics Platform
IMTX
immatics biotechnologies GmbH
IMTXW
5 / 100
$2.25arrow_drop_down6.25%-$0.15

Performance History

Stocklytics logo
Key Stats
Open$2.40
Prev. Close$2.40
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap-
PE Ratio-
LOWHIGH
Day Range2.25
2.40
52 Week Range1.45
4.14
Ratios
P/B Ratio0.00
Revenue-
Operating M. %-174.07%
Earnings$0.00
Earnings Growth %-358.55%
EBITDA Margin %-182.14%
ROE %-44.26%
EPS-

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

5vs 54. Market Avg.

All Score 5 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

IMTXWMARKET
Value040
Quality840
Ownership017
Growth347
Dividends-38
warning

immatics biotechnologies GmbH's Compound annual growth rate in the last 3 years (CAGR) of -23.54% is modest compared to market average of 13.6%. This indicates IMTXW could be an inefficient company.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$363.37
24H (%)arrow_drop_up1.61%
24H ($)$5.76
MARKET CAP$180.16B
PRICE$362.85
24H (%)arrow_drop_down0.52%
24H ($)-$1.89
MARKET CAP$50.81B
PRICE$24.04
24H (%)arrow_drop_down0.04%
24H ($)-$0.01
MARKET CAP$37.28B
PRICE$23.15
24H (%)arrow_drop_up0.17%
24H ($)$0.04
MARKET CAP$36.35B

About immatics biotechnologies GmbH (IMTXW)

No data available
Sector
-
Industry
-
CEO
-
Headquarters
-
Employees
0
Exchange
NASDAQ
add immatics biotechnologies GmbH to watchlist

Keep an eye on immatics biotechnologies GmbH

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is immatics biotechnologies GmbH's (IMTXW) price per share?

The current price per share for immatics biotechnologies GmbH (IMTXW) is $2.25. The stock has seen a price change of -$0.15 recently, indicating a -6.25% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for immatics biotechnologies GmbH (IMTXW)?

For immatics biotechnologies GmbH (IMTXW), the 52-week high is $4.14, which is 84% from the current price. The 52-week low is $1.45, the current price is 55.17% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is immatics biotechnologies GmbH (IMTXW) a growth stock?

immatics biotechnologies GmbH (IMTXW) has shown an average price growth of over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying immatics biotechnologies GmbH as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is immatics biotechnologies GmbH (IMTXW) stock price performance year to date (YTD)?

As of the latest data, immatics biotechnologies GmbH (IMTXW) has a year-to-date price change of -16.36%. Over the past month, the stock has experienced a price change of -27.65%. Over the last three months, the change has been -37.5%. Over the past six months, the figure is 20.97%.

help
Is immatics biotechnologies GmbH (IMTXW) a profitable company?

immatics biotechnologies GmbH (IMTXW) has a net income of -$96.99M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -174.07% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $54M. Operating income is noted at -$101.72M. Furthermore, the EBITDA is -$104.84M.

help
What is the market capitalization of immatics biotechnologies GmbH (IMTXW)?

immatics biotechnologies GmbH (IMTXW) has a market capitalization of . The average daily trading volume is 2.5K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.